HK1130789A1 - Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5- a]pyrimidin-7-yl]-phenyl-n-methyl-acetamide - Google Patents

Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5- a]pyrimidin-7-yl]-phenyl-n-methyl-acetamide

Info

Publication number
HK1130789A1
HK1130789A1 HK09108826.4A HK09108826A HK1130789A1 HK 1130789 A1 HK1130789 A1 HK 1130789A1 HK 09108826 A HK09108826 A HK 09108826A HK 1130789 A1 HK1130789 A1 HK 1130789A1
Authority
HK
Hong Kong
Prior art keywords
pyrazolo
pyrimidin
thiophene
fluoro
carbonyl
Prior art date
Application number
HK09108826.4A
Other languages
English (en)
Inventor
Luis Anglada
Albert Palomer
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of HK1130789A1 publication Critical patent/HK1130789A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK09108826.4A 2006-11-08 2009-09-25 Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5- a]pyrimidin-7-yl]-phenyl-n-methyl-acetamide HK1130789A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86481406P 2006-11-08 2006-11-08
EP06123652A EP1921079A1 (fr) 2006-11-08 2006-11-08 Forme amorphe de N-{2-Fluoro-5-[3-(thiophen-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
PCT/EP2007/062014 WO2008055934A1 (fr) 2006-11-08 2007-11-07 Forme amorphe de n-{2-fluoro-5-[3-(thiophène-2-carbonyl)-pyrazolo [1,5-a] pyrimidin-v-yl]-phényl-n-méthyl-acétamide

Publications (1)

Publication Number Publication Date
HK1130789A1 true HK1130789A1 (en) 2010-01-08

Family

ID=37836942

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108826.4A HK1130789A1 (en) 2006-11-08 2009-09-25 Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5- a]pyrimidin-7-yl]-phenyl-n-methyl-acetamide

Country Status (22)

Country Link
US (1) US8338436B2 (fr)
EP (2) EP1921079A1 (fr)
JP (1) JP5274472B2 (fr)
KR (1) KR101474033B1 (fr)
CN (1) CN101563350B (fr)
AR (1) AR063579A1 (fr)
AU (1) AU2007316607B2 (fr)
BR (1) BRPI0718538A2 (fr)
CA (1) CA2667936C (fr)
CL (1) CL2007003218A1 (fr)
DK (1) DK2086978T3 (fr)
ES (1) ES2402981T3 (fr)
HK (1) HK1130789A1 (fr)
MX (1) MX2009004636A (fr)
NO (1) NO341702B1 (fr)
PL (1) PL2086978T3 (fr)
PT (1) PT2086978E (fr)
RU (1) RU2450005C2 (fr)
SI (1) SI2086978T1 (fr)
TW (1) TWI414526B (fr)
UY (1) UY30651A1 (fr)
WO (1) WO2008055934A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2478640C1 (ru) * 2012-02-07 2013-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" N-АРИЛ-2,3-ДИАРОИЛ-8,10-ДИМЕТИЛПИРИДО[2',3':3,4]ПИРАЗОЛО[1,5-α]ПИРИМИДИН-4-КАРБОКСАМИДЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
WO2006033795A2 (fr) * 2004-09-17 2006-03-30 Wyeth Methode d'utilisation de pyrazolo [1,5-a] pyrimidines substituees
WO2006033796A1 (fr) * 2004-09-17 2006-03-30 Wyeth Pyrazolo [1,5-a] pyrimidines substituees et leur procede de fabrication
CN100528875C (zh) * 2005-02-18 2009-08-19 美德（江西）生物科技有限公司 无结晶型态的印地普隆及其制备方法
EP1736475A1 (fr) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Pyrazolo[1,5-a]pyrimidines halogenées, processus, utilisations, compositions et produits intermédiaires
EP1918290A1 (fr) * 2006-10-11 2008-05-07 Ferrer Internacional, S.A. La polymorphe B de la N-{2-fluoro-5-[3-thiophèn-2-carbonyle)-pyrazolo[1,5-a]pyrimidin-7-yl]-phènyl}-N-methyle-acetamide

Also Published As

Publication number Publication date
EP1921079A1 (fr) 2008-05-14
RU2009121672A (ru) 2010-12-20
PT2086978E (pt) 2013-04-04
JP2010509282A (ja) 2010-03-25
UY30651A1 (es) 2008-05-02
WO2008055934A1 (fr) 2008-05-15
ES2402981T3 (es) 2013-05-13
MX2009004636A (es) 2009-05-27
KR20090091154A (ko) 2009-08-26
NO341702B1 (no) 2018-01-02
EP2086978B1 (fr) 2013-01-23
AU2007316607B2 (en) 2013-02-21
JP5274472B2 (ja) 2013-08-28
PL2086978T3 (pl) 2013-07-31
KR101474033B1 (ko) 2014-12-17
US8338436B2 (en) 2012-12-25
AR063579A1 (es) 2009-02-04
CN101563350B (zh) 2012-11-07
TWI414526B (zh) 2013-11-11
CN101563350A (zh) 2009-10-21
CL2007003218A1 (es) 2008-05-16
EP2086978A1 (fr) 2009-08-12
RU2450005C2 (ru) 2012-05-10
DK2086978T3 (da) 2013-04-15
CA2667936A1 (fr) 2008-05-15
NO20092202L (no) 2009-06-08
AU2007316607A1 (en) 2008-05-15
TW200825086A (en) 2008-06-16
CA2667936C (fr) 2013-10-15
US20100137339A1 (en) 2010-06-03
BRPI0718538A2 (pt) 2013-11-19
SI2086978T1 (sl) 2013-05-31

Similar Documents

Publication Publication Date Title
IL212586A (en) Derivative 3 - (1, 3-benzoxazole-5-yl) pyrzolo [3, 4-d] pyrimidine-4-amine, a pharmaceutical preparation and the use of a drug derivative
HRP20180746T4 (hr) Supstituirani spojevi pirazolo[1,5-]pirimidina kao inhibitori trk kinaze
WO2007138472A3 (fr) Dérivés de la triazolopyridazine
IL195033A0 (en) Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
MY152386A (en) Substituted 6a,7,8,9-tetrahydropyrido[3,2-e] pyrrolo[1,2-a]pyrazin-6(5h)-ones
IL177283A (en) Pyrazolopyrimidine compounds, their use in the preparation of medicines and pharmaceuticals containing them
WO2007050587A3 (fr) Compositions therapeutiques et procedes
WO2006122806A3 (fr) Imidazoquinolines utilises en tant qu'inhibiteurs de kinase lipidique
IL210071A (en) Derivatives of {3– (pyrid – 2 – illmethyl) –3 h– [1, 2, 3] triazolo [4, 5 – d] pyrimidine-5-amine}, their pharmaceutical preparations and their use in drug preparation
ZA200708304B (en) Dipeptidyl Peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
HK1116088A1 (zh) 基於增加活性劑對晶體微粒表面的親和力的藥物配方法
WO2008115974A3 (fr) Analogues de pyrazolopyrimidine et leur utilisation en tant qu'inhibiteurs de kinase mtor et kinase pi3
IL184712A (en) History of pyrzulo-pyrimidine, process of preparation, medicinal preparations containing them and use of pharmaceutical preparations
WO2007120752A3 (fr) Tétrahydroptéridines servant d'inhibiteurs de proteines kinases
MY151075A (en) Crystalline form of a quinolone-carboxamide compound
WO2007071965A3 (fr) Composes chimiques
PL1932522T3 (pl) Środek terapeutyczny do leczenia choroby wątroby zawierający jako składnik czynny pochodną 2-amino-1,3-propanodiolu
TW200745137A (en) Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
IL184448A0 (en) Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use
WO2007058989A3 (fr) Quinazolines utiles en tant que modulateurs de canaux ioniques potentio-dependants
IL192328A (en) Walls of yeast cells for the treatment and protection of plants against diseases caused by pathogenic factors and compounds containing these walls of yeast cells
TW200800984A (en) New compounds
WO2003074529A3 (fr) Derives indolyl-uree de thienopyridines utilises comme agents antiangiogeniques, et leurs methodes d'utilisation
WO2006029210A3 (fr) 1,3-diamines acycliques et leurs utilisations
BRPI0412905A (pt) composição farmacêutica como forma de dosagem sólida e método de fabricação

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191102